The sustained therapeutic benefit lasting at least 6 months from a single treatment is remarkable but mechanistically unexplained. Understanding whether this reflects circular RNA stability, epigenetic changes, or other factors is critical for optimizing dosing strategies and predicting long-term efficacy. Gap type: unexplained_observation Source paper: Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models. (None, None, PMID:40164764)
Landscape Summary: Why do therapeutic effects persist for 6 months after single ds-cRNA administration? is a 0.75 priority gap in neurotherapeutics. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why do therapeutic effects persist for 6 months after single ds-cRNA administration? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: